Gabapentin-Induced Myoclonus in an Elderly Patient with End-Stage Renal Disease: A Case Report
Archives of Medical Reports · 31.03.2025 · 2 (1) · 11-13
DOI: 10.26524/amr.2025.2.4 ↗Kurz gefasst
Fallbericht in der Zeitschrift Archives of Medical Reports, online erschienen am 31.03.2025. Verfasst von Md. Akifur Rahman Farhan.
Abstract (Originalsprache)
Gabapentin is frequently prescribed for neuropathic pain and restless leg syndrome, particularly in patients with end-stage renal disease (ESRD). While generally well tolerated, rare adverse effects such as myoclonus can occur, particularly in those with impaired renal clearance. We report the case of a 72-yearold female with ESRD on maintenance hemodialysis who developed generalized myoclonus following a recent increase in her gabapentin dose. Neurological investigations ruled out structural or infectious causes. Her symptoms resolved completely after discontinuation of gabapentin and supportive care. This case highlights the importance of cautious dosing of renally excreted drugs like gabapentin and monitoring for neurotoxic side effects in dialysis patients.
Zitieren
APA
Farhan, M. A. R. (2025). Gabapentin-Induced Myoclonus in an Elderly Patient with End-Stage Renal Disease: A Case Report. Archives of Medical Reports, 2(1), 11-13. https://doi.org/10.26524/amr.2025.2.4
Vancouver
Farhan MAR. Gabapentin-Induced Myoclonus in an Elderly Patient with End-Stage Renal Disease: A Case Report. Archives of Medical Reports. 2025;2(1):11-13. doi:10.26524/amr.2025.2.4
BibTeX
@article{Farhan2025,
author = {Farhan, Md. Akifur Rahman},
title = {Gabapentin-Induced Myoclonus in an Elderly Patient with End-Stage Renal Disease: A Case Report},
journal = {Archives of Medical Reports},
year = {2025},
volume = {2},
number = {1},
pages = {11--13},
doi = {10.26524/amr.2025.2.4}
}
EUVIMED